Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
Feb 08,2024
Medlab Dubai 2024
Oct 27,2020
WESAIL Appears at 2020 China (Dongguan) International Medical Epidemic Prevention and Big Health Industry Development Forum and Exhibition
From October 19 to 20, 2020, Guangdong Weishi Biotechnology Co., Ltd. participated in the "2020 Dongguan International Medical Epidemic Prevention and Great Health Exhibition"
Mar 30,2021
WESAIL debuts at CACLP to make POCT easier, faster and more accurate
Guangdong Weishi Biotechnology Co., Ltd. (hereinafter referred to as "WESAIL") and its star products independently developed and produced by the company were invited to participate in the flagship expo event of in vitro diagnosis industry -- CACLP.
Nov 17,2021
WESAIL debuts at MEDICA 2021 to share innovations with the world!
Nov 15,2022
More than 50% of Chinese adults have diabetes or are in the pre-disease stage. See here for diagnostic criteria.
Nov 21,2022
"Only" innovation, win the future! Guangdong Weishi biological new products unveiled in 2022 Germany MEDICA medical exhibition